CLDI Earnings Calidi Biotherapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–15 of 15
| Q1 2026 | 2026-03-31 | -0.43 | 2026-05-14 | 10-Q |
| FY 2025 | 2025-12-31 | -5.95 | 2026-03-27 | 10-K |
| Q3 2025 | 2025-09-30 | -6.40 | 2025-11-13 | 10-Q |
| Q2 2025 | 2025-06-30 | -4.17 | 2025-08-08 | 10-Q |
| Q1 2026 | 2025-03-31 | -2.21 | 2026-05-14 | 10-Q |
| FY 2025 | 2024-12-31 | -35.70 | 2026-03-27 | 10-K |
| Q3 2025 | 2024-09-30 | -42.40 | 2025-11-13 | 10-Q |
| Q2 2025 | 2024-06-30 | -39.61 | 2025-08-08 | 10-Q |
| Q1 2025 | 2024-03-31 | -2.03 | 2025-05-14 | 10-Q |
| FY 2024 | 2023-12-31 | -17.33 | 2025-03-31 | 10-K |
| Q3 2024 | 2023-09-30 | -19.80 | 2024-11-12 | 10-Q |
| Q2 2024 | 2023-06-30 | -21.75 | 2024-08-13 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.75 | 2024-05-14 | 10-Q |
| FY 2023 | 2022-12-31 | 2.99 | 2024-03-15 | 10-K |
| Q3 2023 | 2022-09-30 | -2.08 | 2023-11-14 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.